Drug Shortage Report for NEOSTIGMINE OMEGA
Report ID | 200777 |
Drug Identification Number | 02230593 |
Brand name | NEOSTIGMINE OMEGA |
Common or Proper name | Neostigmine Methylsulfate Injection USP |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NEOSTIGMINE METHYLSULFATE |
Strength(s) | 0.5MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 x 10mL vial /fiole |
ATC code | N07AA |
ATC description | PARASYMPATHOMIMETICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-08-03 |
Estimated end date | 2024-03-28 |
Actual end date | 2024-03-26 |
Shortage status | Resolved |
Updated date | 2024-03-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-03-27 | French | Compare |
v12 | 2024-03-27 | English | Compare |
v11 | 2024-03-19 | French | Compare |
v10 | 2024-03-19 | English | Compare |
v9 | 2024-01-15 | French | Compare |
v8 | 2024-01-15 | English | Compare |
v7 | 2023-11-13 | French | Compare |
v6 | 2023-11-13 | English | Compare |
v5 | 2023-08-14 | French | Compare |
v4 | 2023-08-14 | English | Compare |
v3 | 2023-08-04 | English | Compare |
v2 | 2023-08-02 | French | Compare |
v1 | 2023-08-02 | English | Compare |
Showing 1 to 13 of 13